Merck Kgaa
-
{
- All
- News
-
P&G To Buy German Merck's Consumer Health Unit For $4.2 Billion
P&G has agreed to acquire Merck KGaA's consumer health unit for 3.4 billion euros, giving it vitamin brands such as Seven Seas
-
Merck Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
Merck KGaA Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
Germany's Merck to Buy US Firm Sigma-Aldrich for $17 Billion
German drug maker Merck KGaA will acquire US-based Sigma-Aldrich, led by Indian-origin CEO Rakesh Sachdev, for $17 billion in an all cash deal.
-
Glaxo to Pay Merck Up to $4.2 Billion in Cancer Deal
Collaboration is the latest step in Glaxo CEO Emma Walmsley’s effort to rebuild the U.K. company’s position in oncology.
-
Palantir Posted Nearly $1 Billion in 2018 Sales, Executive Says
Roughly half of the revenue came from government agencies, such as U.S. Defense Department, and the rest from corporate clients.
-
P&G To Buy German Merck's Consumer Health Unit For $4.2 Billion
P&G has agreed to acquire Merck KGaA's consumer health unit for 3.4 billion euros, giving it vitamin brands such as Seven Seas
-
Your Tablet Screen is Brought To You With The Aid Of ... Carrots
This Christmas, as consumers around the world hope Santa will give them a smartphone, TV or tablet computer, few people know that the lowly carrot inspired the liquid crystals at the core of such hi-tech gadgets.
-
Germany's Merck to Buy US Firm Sigma-Aldrich for $17 Billion
German drug maker Merck KGaA will acquire US-based Sigma-Aldrich, led by Indian-origin CEO Rakesh Sachdev, for $17 billion in an all cash deal.
-
Merck KGaA Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
Merck Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
P&G To Buy German Merck's Consumer Health Unit For $4.2 Billion
P&G has agreed to acquire Merck KGaA's consumer health unit for 3.4 billion euros, giving it vitamin brands such as Seven Seas
-
Merck Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
Merck KGaA Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
Germany's Merck to Buy US Firm Sigma-Aldrich for $17 Billion
German drug maker Merck KGaA will acquire US-based Sigma-Aldrich, led by Indian-origin CEO Rakesh Sachdev, for $17 billion in an all cash deal.
-
Glaxo to Pay Merck Up to $4.2 Billion in Cancer Deal
Collaboration is the latest step in Glaxo CEO Emma Walmsley’s effort to rebuild the U.K. company’s position in oncology.
-
Palantir Posted Nearly $1 Billion in 2018 Sales, Executive Says
Roughly half of the revenue came from government agencies, such as U.S. Defense Department, and the rest from corporate clients.
-
P&G To Buy German Merck's Consumer Health Unit For $4.2 Billion
P&G has agreed to acquire Merck KGaA's consumer health unit for 3.4 billion euros, giving it vitamin brands such as Seven Seas
-
Your Tablet Screen is Brought To You With The Aid Of ... Carrots
This Christmas, as consumers around the world hope Santa will give them a smartphone, TV or tablet computer, few people know that the lowly carrot inspired the liquid crystals at the core of such hi-tech gadgets.
-
Germany's Merck to Buy US Firm Sigma-Aldrich for $17 Billion
German drug maker Merck KGaA will acquire US-based Sigma-Aldrich, led by Indian-origin CEO Rakesh Sachdev, for $17 billion in an all cash deal.
-
Merck KGaA Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
-
Merck Agrees to Market Lupin Drugs in Emerging Countries
The partnership covers Brazil, Mexico, Indonesia, Philippines as well as several countries in Africa and eastern Europe, among others, Merck said in a statement on Tuesday.
